At a glance
- Originator Bristol-Myers Squibb
- Class Antihypertensives; Heart failure therapies
- Mechanism of Action Angiotensin type 1 receptor antagonists; Angiotensin type 2 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Hypertension